To be the leading provider of analytical, live cell analysis tools that facilitate the transformation of research discoveries into new ways to diagnose and treat patients.
By characterizing molecular and cellular mechanisms in physiologically relevant micro-environments, Fluxion helps bridge the translational medicine gap by bringing research data closer to patients. Our innovative systems for live cell analysis are enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Fluxion is led by an experienced team of professionals from the bioanalytical tool industry. The Board of Directors comprises senior executives and investors representing some of the leading biotech and technology companies in the industry.
Location: South San Francisco, California, USA (directions)
Principal focus: Analytical instruments for functional cellular analyses
- BioFlux System for live cell analysis under shear flow
- IonFlux System for automated patch clamping
- IsoFlux System for circulating tumor cell analysis
Product Development Strategy
Fluxion works closely with its customers and collaborators to develop new products and applications. All of the company's products were the result of extensive product development and testing both internally and with leading academic and biopharmaceutical institutions.
In 2008, BioFlux 200 was the recipient of the R&D 100 Award given by R&D Magazine to the top 100 new technologies of the year. In 2010 and 2013, Fluxion received additional R&D100 awards for the IonFlux HT System and IsoFlux System, respectively.
Advanced Research and Development
In addition to its core product lines, Fluxion is also engaged in cutting-edge research to produce the next generation of breakthrough technologies. Fluxion has been awarded several research grants from the National Institutes of Health to develop platforms for critical disease research areas.
Please contact us with any additional questions regarding our company, products or scientific collaborations.
Fluxion's goal is to create innovative solutions for its customers which offer superior performance, simplified workflows and cost savings over conventional assay techniques. Fluxion's customers include:
• Biotech and pharmaceutical companies - Johnson & Johnson, Pfizer, Genentech
• Leading academic institutions - Harvard, Stanford, UCSF, Cornell
• Government research organizations - NIH, Walter Reed, Lawrence Berkeley